Skip to main content

Recent progresses on early diagnosis of Parkinson’s disease and related disorders

Guest edited by Anthony E. Lang

A thematic series in Translational Neurodegeneration. 

  1. The spectrum of synucleinopathies, including Parkinson’s disease (PD), multiple system atrophy (MSA), and dementia with Lewy bodies (DLB), is characterized by α-synuclein (αSyn) pathology, which serves as the ...

    Authors: Yaoyun Kuang, Hengxu Mao, Xiaoyun Huang, Minshan Chen, Wei Dai, Tingting Gan, Jiaqi Wang, Hui Sun, Hao Lin, Qin Liu, Xinling Yang and Ping-Yi Xu
    Citation: Translational Neurodegeneration 2024 13:56
    Content type: Review Published on:

  2. There is a need for biomarkers to support an accurate diagnosis of Parkinson’s disease (PD). Cerebrospinal fluid (CSF) has been a successful biofluid for finding neurodegenerative biomarkers, and modern highly...

    Authors: Wojciech Paslawski, Shervin Khosousi, Ellen Hertz, Ioanna Markaki, Adam Boxer and Per Svenningsson
    Citation: Translational Neurodegeneration 2023 12:42
    Content type: Research Published on:

  3. Multiple system atrophy (MSA) is a neurodegenerative condition characterized by variable combinations of parkinsonism, autonomic failure, cerebellar ataxia and pyramidal features. Although the distribution of ...

    Authors: Ivan Martinez-Valbuena, Naomi P. Visanji, Ain Kim, Heather H. C. Lau, Raphaella W. L. So, Sohaila Alshimemeri, Andrew Gao, Michael A. Seidman, Maria R. Luquin, Joel C. Watts, Anthony E. Lang and Gabor G. Kovacs
    Citation: Translational Neurodegeneration 2022 11:7
    Content type: Research Published on: